Marion Peters, MD
Professor Emeritus
Medicine
School of Medicine

Websites

Show all (1) Hide

• Profile at UCSF Cancer Center (cancer.ucsf.edu)

Grants and Projects

Show all (8) Hide

• UCSF Liver Center, NIH, 1985-2023
• NRSA Hepatology Training Grant, NIH, 2001-2022
• HIV status and reproductive aging affect liver fibrosis in HIV/HCV infected women, NIH, 2010-2013
• General Clinical Research Center, NIH, 1974-2009
• General Clinical Research Center, NIH, 1974-2009
• Hcv &Alchool-- Epidemiology &Host-virus Correlates, NIH, 2000-2006
• Intestinal Immune Response Inflammatory Bowl Disease, NIH, 1995-2001
• Intestinal Immune Response in Inflammatory Bowel Disease, NIH, 1991-1995

Publications (156)

Top publication keywords:
ViremiaHepatitis BHepatitis B virusCoinfectionHIV InfectionsHepatitis B, ChronicLiverHepatitis B AntibodiesHepatitis CInterferonsHepatitis C, ChronicAntiviral AgentsHepatitis, AutoimmuneLiver CirrhosisHepacivirus

• Chronic Hepatitis B Finite Treatment: similar and different concerns with new drug classes.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2023 Peters MG, Yuen MF, Terrault N, Fry J, Lampertico P, Gane E, Hwang C, Stamm LM, Leus M, Maini MK, Mendez P, Lonjon-Domanec I, Berg T, Wang S, Mishra P, Donaldson E, Buchholz S, Miller V, Lenz O
• Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBV.
  Journal of virus eradication 2023 Kang M, Price JC, Peters MG, Lewin SR, Sulkowski M
• Comparison of Antiretroviral Therapies in Pregnant Women Living With Human Immunodeficiency Virus and Hepatitis B Virus: A Randomized Controlled Trial.
  Obstetrics and gynecology 2023 Bhattacharya D, Tierney C, Butler K, Kiweewa FM, Moodley D, Govender V, Vhembo T, Mohtashemi N, Ship H, Dula D, George K, Chaktoura N, Fowler MG, Peters MG, Currier JS
• Adverse Impact of HIV-1 on Long-term Outcomes Following HCV DAA Treatment: Final Results of ACTG A5320, the Viral Hepatitis C Infection Long-term Cohort Study (VHICS).
  Open forum infectious diseases 2023 Wyles DL, Kang M, Matining RM, Murphy RL, Peters MG
• Hepatocellular carcinoma presentation and prognosis among Nigerian adults with and without HIV.
  PloS one 2023 Davwar PM, Okeke E, Duguru M, Nyam D, Bell K, Odeghe EA, Oyeleke G, Lesi OA, Singh R, Kim KY, Imade G, Akanmu AS, Sagay AS, Ogunsola FT, Peters MG, Roberts LR, Hou L, Murphy RL, Hawkins CA

Show all (151 more) Hide

• Introducing Norah Terrault, MD, MPH, Our 2023 AASLD President.
  Hepatology (Baltimore, Md.) 2023 Peters MG, Lai JC
• Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection.
  Journal of acquired immune deficiency syndromes (1999) 2022 Kiweewa FM, Tierney C, Butler K, Peters MG, Vhembo T, Moodley D, Govender V, Mohtashemi N, Ship H, Musoke P, Dula D, George K, Chakhtoura N, Fowler MG, Currier JS, Bhattacharya D
• Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapy.
  AIDS (London, England) 2022 Hawkins C, Kang M, Bhattacharya D, Cloherty G, Kuhns M, Matining R, Thio C, Samaneka W, Chinula L, Mulinda N, Badal-Faesen S, Sugandhavesa P, Lama J, Gaseitsiwe S, Holzmayer V, Anderson M, Murphy R, …
• Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).
  Open forum infectious diseases 2021 Wyles DL, Kang M, Matining RM, Murphy RL, Peters MG
• Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021 Martin P, Nguyen MH, Dieterich DT, Lau DT, Janssen HLA, Peters MG, Jacobson IM
• Decreases in markers of monocyte/macrophage activation after hepatitis C eradication in HIV/hepatitis C virus coinfected women.
  AIDS (London, England) 2021 French AL, Grennan D, Daubert E, Seaberg EC, Peters M, Augenbraun M, Fischl M, Kassaye S, Franco R, Kuniholm M, Adimora AA, Workowski K, Weber KM
• Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North America.
  Hepatology (Baltimore, Md.) 2021 Kim HN, Newcomb CW, Carbonari DM, Roy JA, Torgersen J, Althoff KN, Kitahata MM, Reddy KR, Lim JK, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Kirk GD, Sun J, Hull M, Gill MJ, Sterling TR, Kostman …
• A Multiancestry Sex-Stratified Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.
  The Journal of infectious diseases 2021 Vergara C, Valencia A, Thio CL, Goedert JJ, Mangia A, Piazzolla V, Johnson E, Kral AH, O'Brien TR, Mehta SH, Kirk GD, Kim AY, Lauer GM, Chung RT, Cox AL, Peters MG, Khakoo SI, Alric L, Cramp ME, …
• Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing Regimens.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 Bhattacharya D, Gupta A, Tierney C, Huang S, Peters MG, Chipato T, Martinson F, Mohtashemi N, Dula D, George K, Chaktoura N, Klingman KL, Gnanashanmugam D, Currier JS, Fowler MG
• Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
  JAMA network open 2021 Sun J, Althoff KN, Jing Y, Horberg MA, Buchacz K, Gill MJ, Justice AC, Rabkin CS, Goedert JJ, Sigel K, Cachay E, Park L, Lim JK, Kim HN, Lo Re V, Moore R, Sterling T, Peters MG, Achenbach CJ, …
• Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplant.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2020 Peters MG, Kottilil S, Terrault N, Amara D, Husson J, Huprikar S, Florman S, Sulkowski MS, Durand CM, Luetkemeyer AF, Rogers R, Grab J, Haydel B, Blumberg E, Dove L, Emond J, Olthoff K, Smith C, …
• Correction: Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection.
  Genes and immunity 2020 Vergara C, Duggal P, Thio CL, Valencia A, O'Brien TR, Latanich R, Timp W, Johnson EO, Kral AH, Mangia A, Goedert JJ, Piazzola V, Mehta SH, Kirk GD, Peters MG, Donfield SM, Edlin BR, Busch MP, …
• Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection.
  Genes and immunity 2020 Vergara C, Duggal P, Thio CL, Valencia A, O'Brien TR, Latanich R, Timp W, Johnson EO, Kral AH, Mangia A, Goedert JJ, Piazzola V, Mehta SH, Kirk GD, Peters MG, Donfield SM, Edlin BR, Busch MP, …
• Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic Hepatitis B Virus Infection: Systematic Review and Meta-analysis.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020 Anderson RT, Choi HSJ, Lenz O, Peters MG, Janssen HLA, Mishra P, Donaldson E, Westman G, Buchholz S, Miller V, Hansen BE
• The Pathogenesis of Liver Disease in People Living With Human Immunodeficiency Virus: The Emerging Role of the Microbiome.
  Clinical liver disease 2020 Kardashian A, Peters MG, Tien PC, Price JC
• HCV treatment barriers among HIV/HCV co-infected patients in the US: a qualitative study to understand low uptake among marginalized populations in the DAA era.
  Journal of public health (Oxford, England) 2019 Nápoles TM, Batchelder AW, Lin A, Moran L, Johnson MO, Shumway M, Luetkemeyer AF, Peters MG, Eagen KV, Riley ED
• Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients.
  Journal of acquired immune deficiency syndromes (1999) 2019 Lo Re V, Newcomb CW, Carbonari DM, Roy JA, Althoff KN, Kitahata MM, Reddy KR, Lim JK, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Kirk GD, Hull M, Gill J, Sterling TR, Kostman JR, Peters MG, Moore…
• HIV and the liver.
  Topics in antiviral medicine 2019 Sherman KE, Peters MG, Thomas DL
• Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019 Naggie S, Fierer DS, Hughes MD, Kim AY, Luetkemeyer A, Vu V, Roa J, Rwema S, Brainard DM, McHutchison JG, Peters MG, Kiser JJ, Marks KM, Chung RT, Acquired Immunodeficiency Syndrome Clinical Trials …
• Metabolic syndrome and liver steatosis occur at lower body mass index in US Asian patients with chronic hepatitis B.
  Journal of viral hepatitis 2019 Clarke WT, Miranda J, Neidich E, Hudock R, Peters MG, Kelly EM
• Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and Immunology.
  Clinics in liver disease 2019 Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K
• Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor Malignancies.
  Clinics in liver disease 2019 Sasadeusz J, Grigg A, Hughes PD, Lim SL, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K
• Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant Recipients.
  Clinics in liver disease 2019 Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K
• Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents.
  Clinics in liver disease 2019 Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K
• Post-sustained Virologic Response Liver Stiffness May Underestimate Fibrosis After Direct Acting Antiviral-containing Therapy.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019 Kardashian A, McKinney J, Huynh N, Yu R, Peters M, Catalli L, Price JC
• Long-Term Use of Azathioprine in the Management of Autoimmune Hepatitis.
  Gastroenterology & hepatology 2019 Peters MG
• Therapeutic trials of biologics in primary biliary cholangitis: An open label study of abatacept and review of the literature.
  Journal of autoimmunity 2019 Bowlus CL, Yang GX, Liu CH, Johnson CR, Dhaliwal SS, Frank D, Levy C, Peters MG, Vierling JM, Gershwin ME
• Direct-acting antiviral treatment for HIV/HCV patients in safety net settings: patient and provider preferences.
  AIDS care 2019 Shumway M, Luetkemeyer AF, Peters MG, Johnson MO, Napoles TM, Riley ED
• Hepatitis B Virus Infection: What Is Current and New.
  Topics in antiviral medicine 2019 Peters MG
• Cost-effectiveness of Hepatitis B Virus Infection Screening and Treatment or Vaccination in 6 High-risk Populations in the United States.
  Open forum infectious diseases 2018 Chahal HS, Peters MG, Harris AM, McCabe D, Volberding P, Kahn JG
• Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.
  Gastroenterology 2018 Vergara C, Thio CL, Johnson E, Kral AH, O'Brien TR, Goedert JJ, Mangia A, Piazzolla V, Mehta SH, Kirk GD, Kim AY, Lauer GM, Chung RT, Cox AL, Peters MG, Khakoo SI, Alric L, Cramp ME, Donfield SM, …
• Universal Screening of Pregnant Women for Hepatitis C: The Time Is Now.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018 Jhaveri R, Broder T, Bhattacharya D, Peters MG, Kim AY, Jonas MM
• Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy.
  Blood 2018 Kusumoto S, Arcaini L, Hong X, Jin J, Kim WS, Kwong YL, Peters MG, Tanaka Y, Zelenetz AD, Kuriki H, Fingerle-Rowson G, Nielsen T, Ueda E, Piper-Lepoutre H, Sellam G, Tobinai K
• A Tough Egg to Crack.
  Journal of hospital medicine 2018 Geha RM, Dhaliwal G, Peters MG, Manesh R
• Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate.
  The Journal of antimicrobial chemotherapy 2018 MacBrayne CE, Marks KM, Fierer DS, Naggie S, Chung RT, Hughes MD, Kim AY, Peters MG, Brainard DM, Seifert SM, Castillo-Mancilla JR, Bushman LR, Anderson PL, Kiser JJ
• Hepatitis B virus infection.
  Nature reviews. Disease primers 2018 Yuen MF, Chen DS, Dusheiko GM, Janssen HLA, Lau DTY, Locarnini SA, Peters MG, Lai CL
• Similar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).
  Open forum infectious diseases 2018 Wyles DL, Kang M, Matining RM, Murphy RL, Peters MG, VHICS Study Team
• An Assessment of the Clinical Accuracy of Ultrasound in Diagnosing Cirrhosis in the Absence of Portal Hypertension.
  Gastroenterology & hepatology 2018 Kelly EMM, Feldstein VA, Parks M, Hudock R, Etheridge D, Peters MG
• Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus.
  The Journal of infectious diseases 2018 Reid M, Ma Y, Scherzer R, Price JC, French AL, Huhn GD, Plankey MW, Peters M, Grunfeld C, Tien PC
• Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy.
  AIDS (London, England) 2018 Willis SJ, Cole SR, Westreich D, Edmonds A, Hurt CB, Albrecht S, Anastos K, Augenbraun M, Fischl M, French AL, Kalapila AG, Karim R, Peters MG, Plankey M, Seaberg EC, Tien PC, Adimora AA
• Macrophage Activation and the Tumor Necrosis Factor Cascade in Hepatitis C Disease Progression Among HIV-Infected Women Participating in the Women's Interagency HIV Study.
  Journal of acquired immune deficiency syndromes (1999) 2017 French AL, Martin JW, Evans CT, Peters M, Kessaye SG, Nowicki M, Kuniholm M, Golub E, Augenbraun M, Desai SN, WIHS
• Moderate Alcohol Use Is Not Associated With Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women: A Prospective Cohort Study.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017 Kelly EM, Dodge JL, Bacchetti P, Sarkar M, French AL, Tien PC, Glesby MJ, Golub ET, Augenbraun M, Plankey M, Peters MG
• Human immunodeficiency virus and liver disease: A comprehensive update.
  Hepatology communications 2017 Sherman KE, Peters MG, Thomas D
• Reproductive Aging and Hepatic Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017 Sarkar M, Dodge JL, Greenblatt RM, Kuniholm MH, DeHovitz J, Plankey M, Kovacs A, French AL, Seaberg EC, Ofotokun I, Fischl M, Overton E, Kelly E, Bacchetti P, Peters MG, Women’s Interagency HIV Study
• Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults.
  AIDS (London, England) 2017 Price JC, Dodge JL, Ma Y, Scherzer R, Korn N, Tillinghast K, Peters MG, Noworolski S, Tien PC
• The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study.
  PloS one 2017 Keating SM, Dodge JL, Norris PJ, Heitman J, Gange SJ, French AL, Glesby MJ, Edlin BR, Latham PS, Villacres MC, Greenblatt RM, Peters MG, Women’s Interagency HIV Study
• Management of Autoimmune Hepatitis in Pregnant Women.
  Gastroenterology & hepatology 2017 Peters MG
• New Direct-Acting Antiviral Agents and Immunomodulators for Hepatitis B Virus Infection.
  Gastroenterology & hepatology 2017 Peters MG, Locarnini S
• Use of Current and New Endpoints in the Evaluation of Experimental Hepatitis B Therapeutics.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017 Block TM, Locarnini S, McMahon BJ, Rehermann B, Peters MG
• Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017 Naggie S, Marks KM, Hughes M, Fierer DS, Macbrayne C, Kim A, Hollabaugh K, Roa J, Symonds B, Brainard DM, McHutchison JG, Peters MG, Kiser JJ, Chung R, AIDS Clinical Trials Group (ACTG) A5327 Study …
• Histology Rings True.
  The New England journal of medicine 2017 Geha R, Peters M, Gill RM, Dhaliwal G
• Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.
  Hepatology (Baltimore, Md.) 2017 Price JC, Ma Y, Scherzer R, Korn N, Tillinghast K, Peters MG, Noworolski SM, Tien PC
• Sonography Predicts Liver Steatosis in Patients With Chronic Hepatitis B.
  Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2017 Kelly EM, Feldstein VA, Etheridge D, Hudock R, Peters MG
• Sex differences in the association of HIV infection with hepatic steatosis.
  AIDS (London, England) 2017 Kardashian A, Ma Y, Scherzer R, Price JC, Sarkar M, Korn N, Tillinghast K, Peters MG, Noworolski SM, Tien PC
• Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017 Balitzer D, Shafizadeh N, Peters MG, Ferrell LD, Alshak N, Kakar S
• Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation.
  Journal of virus eradication 2017 Liu J, Goicochea P, Block T, Brosgart CL, Donaldson EF, Lenz O, Gee Lim S, Marins EG, Mishra P, Peters MG, Miller V
• Screening for hepatocellular carcinoma: What is missing?
  Hepatology communications 2016 Mehta NJ, Celik AD, Peters MG
• Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016 Klein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V, Kirk GD, Hull M, Kim HN, Sebastiani G, Moodie EE, Silverberg MJ, Sterling TR, Thorne JE, Cescon A, Napravnik S, Eron J, Gill MJ, Justice A, …
• Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study.
  Medicine 2016 Desai SN, Dodge JL, Landay AL, Glesby MJ, Latham PS, Villacres MC, French AL, Gange SJ, Greenblatt RM, Peters MG
• Isolated Hepatitis B Core Antibody Status Is Not Associated With Accelerated Liver Disease Progression in HIV/Hepatitis C Coinfection.
  Journal of acquired immune deficiency syndromes (1999) 2016 French AL, Hotton A, Young M, Nowicki M, Augenbraun M, Anastos K, Seaberg E, Rosenberg W, Peters MG
• Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C.
  Journal of acquired immune deficiency syndromes (1999) 2016 Valcour VG, Rubin LH, Obasi MU, Maki PM, Peters MG, Levin S, Crystal HA, Young MA, Mack WJ, Cohen MH, Pierce CB, Adimora AA, Tien PC, Women's Interagency HIV Study Protocol Team
• Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016 Kelly EM, Dodge JL, Sarkar M, French AL, Tien PC, Glesby MJ, Golub ET, Augenbraun M, Plankey M, Peters MG
• Use of Palliative Care Consultation for Patients with End-Stage Liver Disease: Survey of Liver Transplant Service Providers.
  Journal of palliative medicine 2016 Beck KR, Pantilat SZ, O'Riordan DL, Peters MG
• Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin.
  AIDS research and human retroviruses 2016 Petersen T, Lee YJ, Osinusi A, Amorosa VK, Wang C, Kang M, Matining R, Zhang X, Dou D, Umbleja T, Kottilil S, Peters MG
• Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV.
  AIDS (London, England) 2016 Peters MG, Bacchetti P, Boylan R, French AL, Tien PC, Plankey MW, Glesby MJ, Augenbraun M, Golub ET, Karim R, Parkes J, Rosenberg W
• Acute and Chronic Hepatitis E Virus Infection in Human Immunodeficiency Virus-Infected U.S. Women.
  Hepatology (Baltimore, Md.) 2016 Kuniholm MH, Ong E, Hogema BM, Koppelman M, Anastos K, Peters MG, Seaberg EC, Chen Y, Nelson KE, Linnen JM
• Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.
  The Journal of infectious diseases 2015 Swanson S, Ma Y, Scherzer R, Huhn G, French AL, Plankey MW, Grunfeld C, Rosenberg WM, Peters MG, Tien PC
• Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes.
  PloS one 2015 Lang Kuhs KA, Kuniholm MH, Pfeiffer RM, Chen S, Desai S, Edlin BR, Peters MG, Plankey M, Sharp GB, Strickler HD, Villacres MC, Quinn TC, Gange SJ, Prokunina-Olsson L, Greenblatt RM, O'Brien TR
• Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels.
  AIDS (London, England) 2015 Shah S, Ma Y, Scherzer R, Huhn G, French AL, Plankey M, Peters MG, Grunfeld C, Tien PC
• A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2015 Martin P, Lau DT, Nguyen MH, Janssen HL, Dieterich DT, Peters MG, Jacobson IM
• Mother-to-child transmission of hepatitis B virus in sub-Saharan Africa: time to act.
  The Lancet. Global health 2015 Andersson MI, Rajbhandari R, Kew MC, Vento S, Preiser W, Hoepelman AI, Theron G, Cotton M, Cohn J, Glebe D, Lesi O, Thursz M, Peters M, Chung R, Wiysonge C
• Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.
  PloS one 2015 Decaris ML, Emson CL, Li K, Gatmaitan M, Luo F, Cattin J, Nakamura C, Holmes WE, Angel TE, Peters MG, Turner SM, Hellerstein MK
• Direct and Indirect Serum Markers of Liver Fibrosis Compared with Transient Elastography among Women in the Women's Interagency HIV Study.
  Journal of AIDS & clinical research 2015 Kassaye S, Li Y, Huhn G, Peters MG, French AL, Tien PC, Luxon B, Plankey MW
• Survey of Asian patients with hepatitis B infection: limited knowledge of transmission and screening of family members.
  Journal of immigrant and minority health 2015 Vijayan T, Zheng P, Nguyen C, Brown AM, Chen YW, Peters MG
• Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women.
  Journal of acquired immune deficiency syndromes (1999) 2014 Kuniholm MH, Xie X, Anastos K, Kaplan RC, Xue X, Kovacs A, Peters MG, Seaberg EC, French AL, Young MA, Augenbraun M, Martinson JA, Bush KA, Landay AL, Strickler HD
• Advances in therapy for HIV/hepatitis C virus-coinfected patients in the liver transplant setting.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014 Campos-Varela I, Peters MG, Terrault NA
• Characteristics and management of patients with chronic hepatitis B in an integrated care setting.
  Digestive diseases and sciences 2014 Sarkar M, Shvachko VA, Ready JB, Pauly MP, Terrault NA, Peters MG, Manos MM
• Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial.
  HIV clinical trials 2013 Amorosa VK, Luetkemeyer A, Kang M, Johnson VA, Umbleja T, Haas DW, Yesmin S, Bardin MC, Chung RT, Alston-Smith B, Tebas P, Peters MG
• Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes.
  Gastroenterology & hepatology 2013 Guy J, Peters MG
• Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus.
  The Journal of infectious diseases 2013 Aka PV, Kuniholm MH, Pfeiffer RM, Wang AS, Tang W, Chen S, Astemborski J, Plankey M, Villacres MC, Peters MG, Desai S, Seaberg EC, Edlin BR, Strickler HD, Thomas DL, Prokunina-Olsson L, Sharp GB, O'…
• Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B.
  The Journal of clinical investigation 2013 Publicover J, Gaggar A, Nishimura S, Van Horn CM, Goodsell A, Muench MO, Reinhardt RL, van Rooijen N, Wakil AE, Peters M, Cyster JG, Erle DJ, Rosenthal P, Cooper S, Baron JL
• Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography.
  The Journal of infectious diseases 2013 Bailony MR, Scherzer R, Huhn G, Plankey MW, Peters MG, Tien PC
• Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis.
  PloS one 2013 Price H, Dunn D, Pillay D, Bani-Sadr F, de Vries-Sluijs T, Jain MK, Kuzushita N, Mauss S, Núñez M, Nüesch R, Peters M, Reiberger T, Stephan C, Tan L, Gilson R
• Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus.
  The Journal of infectious diseases 2013 French AL, Evans CT, Agniel DM, Cohen MH, Peters M, Landay AL, Desai SN
• Hepatitis C viremia is associated with cytomegalovirus IgG antibody levels in HIV-infected women.
  PloS one 2013 Kuniholm MH, Parrinello CM, Anastos K, Augenbraun M, Plankey M, Nowicki M, Peters M, Golub ET, Lurain N, Landay AL, Strickler HD, Kaplan RC
• Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.
  Annals of internal medicine 2013 Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters MG, Kirk GD, Mehta SH, Cox AL, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Tobler LH, Busch …
• Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women.
  Digestive diseases and sciences 2012 Sarkar M, Bacchetti P, Tien P, Mileti E, French AL, Edlin BR, Keller M, Seaberg E, Nowicki MJ, Young M, Peters MG
• Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women.
  Hepatology (Baltimore, Md.) 2012 Sarkar M, Bacchetti P, French AL, Tien P, Glesby MJ, Nowicki M, Plankey M, Gange S, Sharp G, Minkoff H, Peters MG, Women's Interagency HIV Study (WIHS)
• Untreated HIV infection is associated with higher blood alcohol levels.
  Journal of acquired immune deficiency syndromes (1999) 2012 McCance-Katz EF, Lum PJ, Beatty G, Gruber VA, Peters M, Rainey PM
• Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis.
  AIDS (London, England) 2012 Bambha K, Pierce C, Cox C, French AL, Tien PC, Sharp GB, Augenbraun M, Glesby MJ, Villacres MC, Plankey M, Strickler HD, Gange SJ, Peters MG
• Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012 Thomas DL, Bartlett JG, Peters MG, Sherman KE, Sulkowski MS, Pham PA
• Effects of hepatitis C and HIV on cognition in women: data from the Women's Interagency HIV Study.
  Journal of acquired immune deficiency syndromes (1999) 2012 Crystal H, Kleyman I, Anastos K, Lazar J, Cohen M, Liu C, Pearce L, Golub E, Valcour V, Ho A, Strickler H, Peters M, Kovacs A, Holman S, Kreek MJ, Manly J
• Validation and modification of simplified diagnostic criteria for autoimmune hepatitis in children.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011 Mileti E, Rosenthal P, Peters MG
• Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients.
  AIDS (London, England) 2011 Soriano V, Sherman KE, Rockstroh J, Dieterich D, Back D, Sulkowski M, Peters M
• Resistance patterns and response to entecavir intensification among HIV-HBV-coinfected adults with persistent HBV viremia.
  Journal of acquired immune deficiency syndromes (1999) 2011 Luetkemeyer AF, Charlebois ED, Hare CB, Black D, Smith A, Havlir DV, Peters MG
• The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.
  The Journal of infectious diseases 2011 Kuniholm MH, Gao X, Xue X, Kovacs A, Marti D, Thio CL, Peters MG, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Young MA, Strickler HD, Carrington M
• Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice.
  Hepatology (Baltimore, Md.) 2011 Chou HS, Hsieh CC, Yang HR, Wang L, Arakawa Y, Brown K, Wu Q, Lin F, Peters M, Fung JJ, Lu L, Qian S
• Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C).
  Journal of acquired immune deficiency syndromes (1999) 2010 Sherman KE, Andersen JW, Butt AA, Umbleja T, Alston B, Koziel MJ, Peters MG, Sulkowski M, Goodman ZD, Chung RT, AIDS Clinical Trials Group A5178 Study Team
• Adipose tissue and metabolic factors associated with steatosis in HIV/HCV coinfection: histology versus magnetic resonance spectroscopy.
  Journal of acquired immune deficiency syndromes (1999) 2010 Ghotb A, Noworolski SM, Madden E, Scherzer R, Qayyum A, Pannell J, Ferrell L, Peters M, Tien PC
• Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis.
  Immunobiology 2010 Tu Z, Li Q, Chou HS, Hsieh CC, Meyerson H, Peters MG, Bu H, Fung JJ, Qian S, Lu L, Lin F
• Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus.
  The Journal of infectious diseases 2010 Mosbruger TL, Duggal P, Goedert JJ, Kirk GD, Hoots WK, Tobler LH, Busch M, Peters MG, Rosen HR, Thomas DL, Thio CL
• Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.
  Hepatology (Baltimore, Md.) 2010 Kuniholm MH, Kovacs A, Gao X, Xue X, Marti D, Thio CL, Peters MG, Terrault NA, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Harris TG, Young MA, Strickler HD, …
• Entering the new era of therapy for HBV and HCV infections.
  The Journal of family practice 2010 Peters MG, Perrillo RP, Jacobson IM, Ross DB, Doo EC, Murray JS, Wong JB
• Recommendations for prevention, screening, and diagnosis of HBV and HCV infections.
  The Journal of family practice 2010 Peters MG, Weinbaum C, Tan L, Baine WB, Dienstag JL, Liang TJ, So S
• Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens.
  The Journal of infectious diseases 2010 Sherman KE, Rouster SD, Stanford S, Blackard JT, Shire N, Koziel M, Peters M, Chung RT, AIDS Clinical Trials Group 5071 Study Team
• End-stage liver disease in HIV disease.
  Topics in HIV medicine : a publication of the International AIDS Society, USA 2009 Peters MG
• Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009 French AL, Lin MY, Evans CT, Benning L, Glesby MJ, Young MA, Operskalski EA, Augenbraun M, Peters M
• Special populations with hepatitis B virus infection.
  Hepatology (Baltimore, Md.) 2009 Peters MG
• Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study.
  American journal of kidney diseases : the official journal of the National Kidney Foundation 2009 Tsui J, Vittinghoff E, Anastos K, Augenbraun M, Young M, Nowicki M, Cohen MH, Peters MG, Golub ET, Szczech L
• New therapies for hepatitis C virus infection.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009 Soriano V, Peters MG, Zeuzem S
• Fourth HIV & Hepatitis Coinfection Workshop; June 19-21, 2008; Madrid, Spain.
  HIV clinical trials 2009 Soriano V, Peters M, Rockstroh J
• Risk factors for hepatitis B infection in rural Vietnam.
  Asian Pacific journal of cancer prevention : APJCP 2009 Duong TH, Nguyen PH, Henley K, Peters M
• Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay.
  Hepatology (Baltimore, Md.) 2008 Mayo MJ, Parkes J, Adams-Huet B, Combes B, Mills AS, Markin RS, Rubin R, Wheeler D, Contos M, West AB, Saldana S, Getachew Y, Butsch R, Luketic V, Peters M, Di Bisceglie A, Bass N, Lake J, Boyer T, …
• Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.
  Hepatology (Baltimore, Md.) 2008 Yao FY, Kerlan RK, Hirose R, Davern TJ, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP
• Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.
  AIDS (London, England) 2008 Soriano V, Puoti M, Peters M, Benhamou Y, Sulkowski M, Zoulim F, Mauss S, Rockstroh J
• The challenge of diagnosing autoimmune hepatitis: less is more.
  Hepatology (Baltimore, Md.) 2008 Choi G, Peters MG
• Hepatitis resulting from liver-specific expression and recognition of self-antigen.
  Journal of autoimmunity 2008 Buxbaum J, Qian P, Allen PM, Peters MG
• The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected women.
  AIDS (London, England) 2008 Strickler HD, Howard AA, Peters M, Fazzari M, Yu H, Augenbraun M, French AL, Young M, Gange S, Anastos K, Kovacs A
• Influence of cannabis use on severity of hepatitis C disease.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008 Ishida JH, Peters MG, Jin C, Louie K, Tan V, Bacchetti P, Terrault NA
• Diagnosis and management of hepatitis B virus and HIV coinfection.
  Topics in HIV medicine : a publication of the International AIDS Society, USA 2007 Peters MG
• Role of alphavbeta6 integrin in acute biliary fibrosis.
  Hepatology (Baltimore, Md.) 2007 Wang B, Dolinski BM, Kikuchi N, Leone DR, Peters MG, Weinreb PH, Violette SM, Bissell DM
• Awareness of hepatitis C infection among women with and at risk for HIV.
  Journal of general internal medicine 2007 Cohen MH, Grey D, Cook JA, Anastos K, Seaberg E, Augenbraun M, Burian P, Peters M, Young M, French A
• Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States.
  Hepatology (Baltimore, Md.) 2007 Peters MG, Di Bisceglie AM, Kowdley KV, Flye NL, Luketic VA, Munoz SJ, Garcia-Tsao G, Boyer TD, Lake JR, Bonacini M, Combes B, PUMPS Group
• Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007 Tsui JI, French AL, Seaberg EC, Augenbraun M, Nowicki M, Peters M, Tien PC
• Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategies.
  Hepatology international 2007 Lau G, Marcellin P, Peters M
• HIV and liver disease forum: conference proceedings.
  Hepatology (Baltimore, Md.) 2007 Sherman KE, Peters M, Koziel MJ
• Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.
  AIDS (London, England) 2007 Soriano V, Puoti M, Sulkowski M, Cargnel A, Benhamou Y, Peters M, Mauss S, Bräu N, Hatzakis A, Pol S, Rockstroh J
• Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007 Behler CM, Vittinghoff E, Lin F, Chung RT, Peters MG, Robbins GK, Volberding PA
• Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women.
  The Journal of infectious diseases 2007 French AL, Operskalski E, Peters M, Strickler HD, Tien PC, Sharp GB, Glesby MJ, Young M, Augenbraun M, Seaberg E, Kovacs A
• Viral hepatitis in HIV infection.
  The New England journal of medicine 2007 Koziel MJ, Peters MG
• Viral factors associated with cytokine expression during HCV/HIV co-infection.
  Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2007 Blackard JT, Kang M, St Clair JB, Lin W, Kamegaya Y, Sherman KE, Koziel MJ, Peters MG, Andersen J, Chung RT, Aids Clinical Trials Group A5071 Study Team
• Effects of HCV treatment on cytokine expression during HCV/HIV coinfection.
  Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2006 Blackard JT, Kang M, Sherman KE, Koziel MJ, Peters MG, Chung RT
• Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.
  Hepatology (Baltimore, Md.) 2006 Peters MG, Andersen J, Lynch P, Liu T, Alston-Smith B, Brosgart CL, Jacobson JM, Johnson VA, Pollard RB, Rooney JF, Sherman KE, Swindells S, Polsky B, ACTG Protocol A5127 Team
• Novel model of antigen-specific induction of bile duct injury.
  Gastroenterology 2006 Buxbaum J, Qian P, Khuu C, Shneider BL, Daikh DI, Gershwin ME, Allen PM, Peters MG
• De novo malignancies following liver transplantation: a case-control study with long-term follow-up.
  Clinical transplantation 2006 Yao FY, Gautam M, Palese C, Rebres R, Terrault N, Roberts JP, Peters MG
• Eosinophilic hepatitis caused by lamotrigine.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006 Fix OK, Peters MG, Davern TJ
• Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection.
  AIDS (London, England) 2006 Graham CS, Wells A, Liu T, Sherman KE, Peters M, Chung RT, Bhan AK, Andersen J, Koziel MJ, ACTG 5071 Study Team
• Chronic hepatitis B: a critical appraisal of current approaches to therapy.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006 Perrillo RP, Gish RG, Peters M, Keeffe EB, Alberti A, Buti M, Cooksley WG, Fried MW, Hadziyannis SJ, Liaw YF, Naoumov NV, Schiff ER, Thio CL, Tsai N, Schalm S
• Clinical presentation and course of acute hepatitis C infection in HIV-infected patients.
  Journal of acquired immune deficiency syndromes (1999) 2006 Luetkemeyer A, Hare CB, Stansell J, Tien PC, Charlesbois E, Lum P, Havlir D, Peters M
• Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.
  Hepatology (Baltimore, Md.) 2005 Combes B, Emerson SS, Flye NL, Munoz SJ, Luketic VA, Mayo MJ, McCashland TM, Zetterman RK, Peters MG, Di Bisceglie AM, Benner KG, Kowdley KV, Carithers RL, Rosoff L, Garcia-Tsao G, Boyer JL, Boyer TD,…
• Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005 Guy JE, Qian P, Lowell JA, Peters MG
• Managing hepatitis B coinfection in HIV-infected patients.
  Current HIV/AIDS reports 2005 Peters MG
• Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection.
  AIDS (London, England) 2005 Graham CS, Wells A, Liu T, Sherman KE, Peters M, Chung RT, Bhan AK, Andersen J, Koziel MJ, ACTG 5071 Study Team
• Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients.
  Gastroenterology 2005 Sherman KE, Shire NJ, Rouster SD, Peters MG, James Koziel M, Chung RT, Horn PS
• Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.
  The New England journal of medicine 2004 Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C, AIDS Clinical Trials Group A5071 Study Team
• Antiviral therapy: nucleotide and nucleoside analogs.
  Clinics in liver disease 2004 Quan DJ, Peters MG
• Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis.
  The American journal of gastroenterology 2004 Combes B, Luketic VA, Peters MG, Zetterman RK, Garcia-Tsao G, Munoz SJ, Lin D, Flye N, Carithers RL
• Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.
  Gastroenterology 2004 Peters MG, Hann Hw Hw, Martin P, Heathcote EJ, Buggisch P, Rubin R, Bourliere M, Kowdley K, Trepo C, Gray Df Df, Sullivan M, Kleber K, Ebrahimi R, Xiong S, Brosgart CL
• Hepatitis C and alcohol: fundamental and translational research directions.
  Alcoholism, clinical and experimental research 2003 Morgan TR, Brenner D, Everhart J, French SW, Fried MW, Gretch DR, Koziel MJ, McClain CJ, Peters MG, Weinman SA, Lucas DL
• Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.
  Radiology 2003 Teefey SA, Hildeboldt CC, Dehdashti F, Siegel BA, Peters MG, Heiken JP, Brown JJ, McFarland EG, Middleton WD, Balfe DM, Ritter JH
• Animal models of autoimmune liver disease.
  Immunology and cell biology 2002 Peters MG